Servier S.A.S. Deal History & Licensing Activity
Servier S.A.S. is a life sciences. Over the past three years, Servier S.A.S. has been involved in 2 licensing and acquisition transactions, with a primary focus on Small Molecules (4 deals).
Deals (12mo)
2
Active Trials
0
Top Modality
Small Molecules
Focus Area
Mega Deals
Servier S.A.S. Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Servier S.A.S. in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| Muscular dystrophy program | Servier | Small Molecules | Unknown | license | Jun 15, 2026 |
| EDG-5506 | Servier | Small Molecules | Phase 2 | acquisition | Jun 3, 2026 |
Servier S.A.S. Pipeline Focus
Therapeutic areas and modalities where Servier S.A.S. is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
See How Your Asset Matches Servier S.A.S.'s Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Mega Deals assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Servier S.A.S. Licensing & Deal Activity
Servier S.A.S. is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 2 deals over the past three years, Servier S.A.S. ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Servier S.A.S. include Mega Deals (4 deals and trials). In terms of modality, Servier S.A.S. has shown particular interest in small molecules.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Servier S.A.S. and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Servier S.A.S.'s historical deal terms, or explore all company profiles to find the best partner match for your pipeline.